Change search
ReferencesLink to record
Permanent link

Direct link
What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication?: Experiences from reports to consumer association
Nordic School of Public Health (NHV), Gothenburg.
Linköping University, Department of Behavioural Sciences and Learning, Education and Sociology. Linköping University, Faculty of Arts and Sciences.
Lund University.
Medical Products Agency, Uppsala.
2011 (English)In: BMC Clinical Pharmacology, ISSN 1472-6904, Vol. 11, no 16Article in journal (Refereed) Published
Abstract [en]


According to the World Health Organization (WHO) the cost of adverse drug reactions   (ADRs) in the general population is high and under-reporting by health professionals   is a well-recognized problem. Another way to increase ADR reporting is to let the   consumers themselves report directly to the authorities. In Sweden it is mandatory   for prescribers to report serious ADRs to the Medical Products Agency (MPA), but there   are no such regulations for consumers. The non-profit and independent organization   Consumer Association for Medicines and Health, KILEN has launched the possibility   for consumers to report their perceptions and experiences from their use of medicines   in order to strengthen consumer rights within the health care sector. This study aimed   to analyze these consumer reports.


All reports submitted from January 2002 to April 2009 to an open web site in Sweden   where anyone could report their experience with the use of pharmaceuticals were analyzed   with focus on common psychiatric side effects related to antidepressant usage. More   than one ADR for a specific drug could be reported.


In total 665 reports were made during the period. 442 reports concerned antidepressant   medications and the individual antidepressant reports represented 2392 ADRs and 878   (37%) of these were psychiatric ADRs. 75% of the individual reports concerned serotonin-reuptake   inhibitor (SSRI) and the rest serotonin-norepinephrine reuptake inhibitor (SNRI).   Women reported more antidepressant psychiatric ADRs (71%) compared to men (24%). More   potentially serious psychiatric ADRs were frequently reported to KILEN and withdrawal   symptoms during discontinuation were also reported as a common issue.


The present study indicates that consumer reports may contribute with important information   regarding more serious psychiatric ADRs following antidepressant treatment. Consumer   reporting may be considered a complement to traditional ADR reporting.

Place, publisher, year, edition, pages
2011. Vol. 11, no 16
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-78151DOI: 10.1186/1472-6904-11-16OAI: diva2:531511
Available from: 2012-06-07 Created: 2012-06-07 Last updated: 2014-03-06

Open Access in DiVA

fulltext(283 kB)101 downloads
File information
File name FULLTEXT01.pdfFile size 283 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Svensson, Tommy
By organisation
Education and SociologyFaculty of Arts and Sciences
In the same journal
BMC Clinical Pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 101 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 52 hits
ReferencesLink to record
Permanent link

Direct link